Skip to Main Content

Paper Details

Long-term quantitative hepatitis B surface antigen (HBsAg) trajectories in persons with and without HBsAg loss on tenofovir-containing antiretroviral therapy.
HIV Med
1
2024
HBV, HBsAg, HIV, hepatitis B, hepatitis B surface antigen, participants, persons, qHBsAg, tenofovir
Author NameAffiliation
Matthias CavassiniLausanne University Hospital, University of Lausanne
Matthias CavassiniLausanne University Hospital, University of Lausanne
  • 1 - 2

Datasets

Release 1.2